SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-133381
Filing Date
2021-11-03
Accepted
2021-11-03 08:10:17
Documents
17
Period of Report
2021-10-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131541d1_8k.htm   iXBRL 8-K 37165
2 EXHIBIT 10.1 tm2131541d1_ex10-1.htm EX-10.1 175038
3 EXHIBIT 10.2 tm2131541d1_ex10-2.htm EX-10.2 216923
4 EXHIBIT 99.1 tm2131541d1_ex99-1.htm EX-99.1 12053
8 GRAPHIC tm2131541d1_ex10-2sp1img001.jpg GRAPHIC 4057
9 GRAPHIC tm2131541d1_ex99-1img001.jpg GRAPHIC 2639
  Complete submission text file 0001104659-21-133381.txt   726947

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cara-20211028.xsd EX-101.SCH 3213
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20211028_lab.xml EX-101.LAB 34594
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20211028_pre.xml EX-101.PRE 22729
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2131541d1_8k_htm.xml XML 3733
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 211373790
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences